02/26/2026
Scientists found a biological "off-switch" for pain.
And it is significantly more active in males than females.
A groundbreaking study from Michigan State University reveals that pain recovery is not a passive process, but an active immune response driven by specific cells called monocytes. These cells produce interleukin-10 (IL-10), a signaling molecule that instructs pain-sensing neurons to quiet down after an injury. Researchers discovered that males possess significantly more active IL-10-producing monocytes than females, a difference directly linked to s*x hormones like testosterone. When these hormones were blocked in animal models, the male advantage in pain resolution disappeared, highlighting a biological mechanism rather than just a difference in perception or reporting.
The findings, confirmed in both mice and human patients, offer a long-sought explanation for why chronic pain disproportionately affects women. Because pain resolution depends on this active immune signaling, weaker IL-10 activity can cause discomfort to persist far longer than necessary. This discovery shifts the medical focus from merely blocking pain sensations to understanding why the biological "off-switch" fails to engage. By targeting this specific pathway, researchers hope to develop new non-opioid therapies that boost the body's natural ability to shut down pain before it becomes a chronic condition.
source: Michigan State University. (2026). Monocyte-derived IL-10 drives s*x differences in pain duration. Science Immunology.